ClassID:

94364

C07D231/04 - CPC Classification

Classification description:

Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members

Recent Application in this class:
#1
20260132119
2026-05-14

Alkylphenyl Substituted Compounds, Compositions and Methods of Use

#2
20260049159
2026-02-19

ANTIBODY-ALK5 INHIBITOR CONJUGATES AND THEIR USES

#3
20240009153
2024-01-11

BUMETANIDE ANALOGS, COMPOSITIONS AND METHODS OF USE

#4
20230159450
2023-05-25

DIMERS FOR USE IN SYNTHESIS OF PEPTIDOMIMETICS

#5
20230132568
2023-05-04

ANTIBODY-ALK5 INHIBITOR CONJUGATES AND THEIR USES

#6
20220071935
2022-03-10

BUMETANIDE ANALOGS, COMPOSITIONS AND METHODS OF USE

#7
20220048849
2022-02-17

Decarboxylase inhibitors for treating Parkinson's disease

#8
20220041641
2022-02-10

QUATERNARY AMMONIUM SALTS AS INHIBITORS OF TRIMETHYLAMINE PRODUCTION

#9
20210061766
2021-03-04

Producing method for 3-difluoromethylpyrazole compound, producing method for 3-difluoromethylpyrazole-4-carboxylic acid compound, and pyrazolidine compound

#10
20200182617
2020-06-11

Necrosis inhibitors

#11
20190154662
2019-05-23

Method of drug design and optimisation utilizing stereochemical mimicry

#12
20190151263
2019-05-23

BUMETANIDE ANALGOS, COMPOSITIONS, AND METHODS OF USE

#13
20190038578
2019-02-07

Necrosis inhibitors

#14
20180230104
2018-08-16

Process for preparing crystalline methyl N- [2- [[[1-(4-chlorophenyl)-1H-pyrazol-3-yl]oxy]methyl]phenyl]-N-methoxycarbamate

#15
20180099977
2018-04-12

Inhibitors of histone deacetylase

#16
20180016282
2018-01-18

INHIBITORS OF HISTONE DEACETYLASE

#17
20160347761
2016-12-01

Inhibitors of histone deacetylase

#18
20160326110
2016-11-10

Substituted 5 membered heterocyclic compounds and preparation thereof

#19
20160251351
2016-09-01

Inhibitors of histone deacetylase

#20
20150080350
2015-03-19

Bumetanide analogs, compositions and methods of use

#21
20140357872
2014-12-04

Organocatalytic synthesis of chiral pyrazolidines and their analogues

#22
20140179687
2014-06-26

Inhibitors of cyclophilins and uses thereof

#23
20130018044
2013-01-17

Inhibitors of cyclophilins and uses thereof

#24
20120004225
2012-01-05

BUMETANIDE, FUROSEMIDE, PIRETANIDE, AZOSEMIDE, AND TORSEMIDE ANALOGS, COMPOSITIONS AND METHODS OF USE

#25
20120004198
2012-01-05

Phenylalanine derivatives and their use as non-peptide GLP-1 receptor modulators

#26
20110245204
2011-10-06

Cycloalkane-containing sphingosine 1-phosphate agonists

#27
20110237783
2011-09-29

Hydrazonopyrazole derivatives and their use as therapeutics

#28
20110028462
2011-02-03

Niacin Receptor Agonists, compositions Containing Such Compounds and Methods of Treatment

#29
20100269269
2010-10-28

Azo derivatives containing a pyrazolinone unit for dyeing keratin fibres

#30
20090093464
2009-04-09

Naphthalene Derivatives as Modulators of the Glucocorticoid Receptor

#31
20080249070
2008-10-09

Cycloalkane-containing sphingosine 1-phosphate agonists

#32
20080153892
2008-06-26

Inhibitors of glutaminyl cyclase

#33
20070191614
2007-08-16

Process for producing nitrogenous 5-membered cyclic compound

#34
20060281686
2006-12-14

Aza-peptides

#35
20060128811
2006-06-15

Antibacterial agents

#36
20050272709
2005-12-08

Hydrazonopyrazole derivatives and their use as therapeutics

#37
20050054680
2005-03-10

Agonists and antagonists of 5h3-like receptors of invertebrates as pesticides

#38
18189387
2024-05-21

ALK5 inhibitors and their uses